Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma
NCT05316467Phase 3Terminated
- Start
- May 2022
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of megestrol in endometrial carcinoma. Started May 2022; status: terminated.
02
Drugs
megestrol
03
Conditions
endometrial carcinoma
Beyond the preview
Go deeper on NCT05316467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05316467.